‘TREMOR’ is a Phase II clinical trial located at Icon Cancer Centre Richmond, Victoria and involves one treatment session of high dose, highly targeted stereotactic radiation therapy, followed by ongoing neurological assessments. Conventional treatment for essential tremor or Parkinson’s related tremor involves deep brain stimulation, an invasive surgical procedure which many patients are unsuitable for due to advancing age, current medications, and/or medical conditions.

This clinical trial offers a non-invasive potential new treatment option for patients.

The clinical trial is currently open for recruitment and continues Icon’s commitment to the increased development and utilisation of radiation therapy both in the treatment of cancer and beyond oncology.

Funding for the TREMOR clinical trial was provided by the Epworth Medical Foundation, Icon Cancer Foundation and supported in kind by Icon Cancer Centre.

Learn more about the clinical trial by downloading the flyer on this page.